Provided by Tiger Trade Technology Pte. Ltd.

Sensei Biotherapeutics, Inc.

29.37
-0.6300-2.10%
Pre-market: 29.370.00000.00%05:21 EDT
Volume:128.36K
Turnover:3.73M
Market Cap:37.04M
PE:-1.53
High:29.86
Open:29.86
Low:28.21
Close:30.00
52wk High:36.76
52wk Low:5.00
Shares:1.26M
Float Shares:828.30K
Volume Ratio:0.91
T/O Rate:15.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-19.1560
EPS(LYR):-24.0130
ROE:-70.18%
ROA:-37.04%
PB:1.61
PE(LYR):-1.22

Loading ...

What Sparked Sensei Biotherapeutics (SNSE) Stock's Nearly 63% After‑Hours Jump?

Benzinga_recent_news
·
Dec 05, 2025

Sensei Biotherapeutics Inc. Files Initial Statement of Beneficial Ownership for President & PEO Christopher Gerry

Reuters
·
Nov 25, 2025

Sensei Biotherapeutics Reports Strategic Shift in Q3 2025

TIPRANKS
·
Nov 15, 2025

Sensei Biotherapeutics Q3 loss narrows; reduces workforce by 65%

Reuters
·
Nov 14, 2025

Sensei Biotherapeutics Q3 EPS $(3.62) Beats $(4.11) Estimate

Benzinga
·
Nov 14, 2025

Sensei Biotherapeutics reports Q3 EPS ($3.62) vs ($5.77) last year

TIPRANKS
·
Nov 14, 2025

Sensei Biotherapeutics Inc - Reduces Workforce by 65 Percent

THOMSON REUTERS
·
Nov 14, 2025

Press Release: Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

Dow Jones
·
Nov 14, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Fiserv, CMS Energy, Moderna

Reuters
·
Oct 31, 2025

Sensei Biotherapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Oct 31, 2025

H.C. Wainwright downgrades Sensei on shelving of solnerstotug

TIPRANKS
·
Oct 30, 2025

Sensei Biotherapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
Oct 30, 2025

BUZZ-Sensei falls as it scraps cancer drug development, plans to sell itself

Reuters
·
Oct 30, 2025

Sensei Biotherapeutics Discontinues Solnerstotug Development

TIPRANKS
·
Oct 30, 2025

Sensei Biotherapeutics Inc - Exploring Strategic Alternatives Including Sale, Merger, or Wind-Down

THOMSON REUTERS
·
Oct 30, 2025

Sensei Biotherapeutics Inc: Plans to Retain Small Team of Employees to Assist in Exploring Strategic Alternatives

THOMSON REUTERS
·
Oct 30, 2025

Sensei Biotherapeutics Inc - Company Expects Workforce Reduction to Preserve Cash

THOMSON REUTERS
·
Oct 30, 2025

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value

GlobeNewswire
·
Oct 30, 2025

Sensei Biotherapeutics Inc trading halted, news pending

TIPRANKS
·
Oct 30, 2025

Sensei Biotherapeutics Inc. releases data on Solnerstotug in PD-(L)1 resistant tumors

Reuters
·
Oct 20, 2025